RNR Home Investment Highlights Valuation & Metrics Price Chart Why The Stock Moved Return vs. Risk About RNR Interactive Breakdown Better Bets vs. RNR Peer Outperformance Latest Trefis Analyses Trade Ideas More From Trefis Peer Comparisons FDIC Bank Data FDA Approved Drugs Data Clinical Pipeline Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Forward Guidance Insider Activity Investor Activity (13F) Trade Sentinel Investor Videos Industry Resource Links External Quote Links

    RenaissanceRe (RNR)

    Market Price (10/13/2026): $338.94 | Market Cap: $14.0 BilSector: Financials | Industry: Reinsurance

    RenaissanceRe (RNR)

    Market Price (10/13/2026): $338.94
    Market Cap: $14.0 Bil
    Sector: Financials
    Industry: Reinsurance

    Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

    0

    Attractive yield
    Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 19%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 15%, FCF Yield is 26%

    Cash is significant % of market cap
    Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -78%

    Attractive cash flow generation
    CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 33%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 33%, CFO LTM is 3.6 Bil, FCF LTM is 3.6 Bil

    Stock buyback support
    Stock Buyback 3Y Total is 3.0 Bil

    Low stock price volatility
    Vol 12M is 24%

    Megatrend and thematic drivers
    Megatrends include Renewable Energy Transition, and Offshore Wind Development. Themes include Solar Energy Generation, Wind Energy Development, Show more.

    Trading close to highs
    Dist 52W High is 0.0%, Dist 3Y High is 0.0%

    Weak multi-year price returns
    2Y Excs Rtn is -2.0%, 3Y Excs Rtn is -16%

    Weak revenue growth
    Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -14%, Rev Chg QQuarterly Revenue Change % is -14%

    Key risks
    RNR key risks include [1] significant financial volatility from its inherent exposure to catastrophic events and [2] pressure on profit margins from escalating operational costs and rising interest expenses on elevated debt.

    0 Attractive yield
    Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 19%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 15%, FCF Yield is 26%
    1 Cash is significant % of market cap
    Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -78%
    2 Attractive cash flow generation
    CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 33%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 33%, CFO LTM is 3.6 Bil, FCF LTM is 3.6 Bil
    3 Stock buyback support
    Stock Buyback 3Y Total is 3.0 Bil
    4 Low stock price volatility
    Vol 12M is 24%
    5 Megatrend and thematic drivers
    Megatrends include Renewable Energy Transition, and Offshore Wind Development. Themes include Solar Energy Generation, Wind Energy Development, Show more.
    6 Trading close to highs
    Dist 52W High is 0.0%, Dist 3Y High is 0.0%
    7 Weak multi-year price returns
    2Y Excs Rtn is -2.0%, 3Y Excs Rtn is -16%
    8 Weak revenue growth
    Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -14%, Rev Chg QQuarterly Revenue Change % is -14%
    9 Key risks
    RNR key risks include [1] significant financial volatility from its inherent exposure to catastrophic events and [2] pressure on profit margins from escalating operational costs and rising interest expenses on elevated debt.

    RNR in ETFs

    Weight = RNR's share of each fund

    VTI0.02%
    ITOT0.02%
    IWB0.02%
    IJH0.40%
    VIG0.06%
    VB0.17%
    NUSC1.0%
    MDYG0.40%
    +24 more covered ETFs

    Valuation & Metrics

    FYE: 12/31RNR [1]S&P 500 [2]
    REVENUE GROWTH
    LTM Revenue [3]$11.1 Bil—
    FY 2026 Sales$8.2 Bil—
    FY 2027 Sales$7.9 Bil—
    FY 2026 Sales Growth-26.3%—
    FY 2027 Sales Growth-3.5%13.1%
    EARNINGS
    LTM Net Income (GAAP) [3]$2.6 Bil—
    FY 2026 Net Income (Non-GAAP)$1.9 Bil—
    FY 2027 Net Income (Non-GAAP)$1.8 Bil—
    FY 2027 Net Income Growth-7.0%18.9%
    FY 2026 EPS (Non-GAAP)$45.96—
    FY 2027 EPS (Non-GAAP)$41.48—
    FY 2027 EPS Growth-9.7%—
    VALUATION
    FY 2026 P/S1.71.7
    FY 2027 P/S1.8—
    FY 2026 P/E7.37.9
    FY 2027 P/E7.8—

    [1] RNR forward figures are analyst consensus for the next two fiscal years (fiscal year end 12/31). Net Income and EPS are non-GAAP (adjusted) consensus. P/S and P/E divide the current market cap by the consensus figure.
    [2] S&P 500 figures are the SPY ETF's holdings-weighted forward aggregate. P/S and P/E reflect FY1/FY2 consensus blended to the 12-month window ending 10/31/27 (~one year forward), shown when ≥90% of index weight has estimates. Growth is the aggregate next-fiscal-year vs current-fiscal-year (FY1→FY2) change. Index-level dollar Sales, Net Income and EPS are not applicable.
    [3] LTM = reported trailing-twelve-month actuals (GAAP).
    RNRS&P 500
    REVENUE GROWTHPOOR
    Rev LTM ($ Bil)11.1
    Rev Chg Q-13.7%9.3%
    Rev Chg LTM-14.1%8.3%
    Rev Chg 3Y Avg17.1%5.9%
    PROFITABILITYGOOD
    Op Inc LTM ($ Bil)�
    CFO LTM ($ Bil)3.6
    Net Inc LTM ($ Bil)2.6
    CFO/Rev LTM32.6%21.9%
    Net Inc Mgn23.8%13.3%
    VALUATIONVERY LOW
    P/S1.33.1
    P/CFO3.914.7
    P/FCF3.919.0
    P/E5.321.9

    AI Analysis | Feedback

    MetricValueDateSource
    Fee Income$101.8 million9302025Link
    Third-Party Capital Under Management$8.09 billion6302025Link
    Net Income Attributable to Redeemable Noncontrolling Interests$415.2 million9302025Link

    Price Chart

    No Events

    Why The Stock Moved

    Qualitative Assessment

    AI Analysis | Feedback

    Updated on 10/12/2026

    RenaissanceRe (RNR) stock has gained about 5% since 6/30/2026 because of the following key factors:

    1. Strong Q2 2026 Financial Performance Exceeded Expectations.

    RenaissanceRe reported robust financial results for its fiscal Q2 2026, which ended on June 30, 2026. The company posted operating earnings per share (EPS) of $12.92, significantly surpassing the consensus analyst estimate of $11.72 by $1.20. Quarterly revenue also exceeded expectations, coming in at $2.77 billion against an estimated $2.57 billion. Furthermore, underwriting profitability improved, with the combined ratio decreasing by 2.3 percentage points to 72.8% compared to fiscal Q2 2025. The book value per common share also saw a healthy increase of 5.7% to $264.77 at the end of fiscal Q2 2026 from March 31, 2026, and the annualized operating return on equity was 20.1%.

    2. Favorable Analyst Upgrades and Price Target Increases.

    Analyst sentiment around RenaissanceRe improved during the specified period, with several firms upgrading their ratings and increasing price targets. Jefferies Financial Group, for instance, upgraded RenaissanceRe from a "hold" rating to a "market outperform" rating on September 22, 2026. Additionally, Bank of America raised its price target from $410.00 to $438.00 with a "buy" rating on July 23, 2026. Keefe, Bruyette & Woods also increased their price target to $350.00, citing improved earnings estimates for 2026 and 2027. Mizuho raised its price target to $338.00, reflecting the fiscal Q2 earnings beat and adjustments to future earnings estimates.

    Show more
    Updated on 10/12/2026

    RenaissanceRe (RNR) stock has gained about 5% since 6/30/2026 because of the following key factors:

    1. Strong Q2 2026 Financial Performance Exceeded Expectations.

    RenaissanceRe reported robust financial results for its fiscal Q2 2026, which ended on June 30, 2026. The company posted operating earnings per share (EPS) of $12.92, significantly surpassing the consensus analyst estimate of $11.72 by $1.20. Quarterly revenue also exceeded expectations, coming in at $2.77 billion against an estimated $2.57 billion. Furthermore, underwriting profitability improved, with the combined ratio decreasing by 2.3 percentage points to 72.8% compared to fiscal Q2 2025. The book value per common share also saw a healthy increase of 5.7% to $264.77 at the end of fiscal Q2 2026 from March 31, 2026, and the annualized operating return on equity was 20.1%.

    2. Favorable Analyst Upgrades and Price Target Increases.

    Analyst sentiment around RenaissanceRe improved during the specified period, with several firms upgrading their ratings and increasing price targets. Jefferies Financial Group, for instance, upgraded RenaissanceRe from a "hold" rating to a "market outperform" rating on September 22, 2026. Additionally, Bank of America raised its price target from $410.00 to $438.00 with a "buy" rating on July 23, 2026. Keefe, Bruyette & Woods also increased their price target to $350.00, citing improved earnings estimates for 2026 and 2027. Mizuho raised its price target to $338.00, reflecting the fiscal Q2 earnings beat and adjustments to future earnings estimates.

    3. Upward Revisions in Fiscal Year 2026 Earnings Estimates.

    Analysts revised their earnings per share (EPS) estimates for RenaissanceRe upwards for the full fiscal year 2026. DOWLING & PARTN, for example, increased its FY2026 EPS forecast to $44.00 per share from a previous estimate of $40.00 per share in a report released on October 7, 2026. This upward adjustment in future earnings expectations signals increased confidence in the company's sustained profitability.

    4. Calm Atlantic Hurricane Season Reduced Catastrophe Exposure.

    A relatively calm Atlantic hurricane season, as noted by Jefferies, with only five named storms and no hurricanes reported, has positively impacted the outlook for the reinsurance industry, including RenaissanceRe. For a reinsurer specializing in property catastrophe coverage, a quiet hurricane season directly translates to a reduction in potential claims, thus improving the prospects for a profitable fiscal Q3 2026.

    Show less
    Holding a concentrated position? Know your true downside before the momentum shifts.
    Protect Your Wealth →

    Stock Movement Drivers

    Fundamental Drivers

    The 7.1% change in RNR stock from 6/30/2026 to 10/12/2026 was primarily driven by a 11.2% change in the company's P/E Multiple.
    (LTM values as of)630202610122026Change
    Stock Price ($)316.51338.877.1%
    Change Contribution By: 
    Total Revenues ($ Mil)11,49911,063-3.8%
    Net Income Margin (%)24.4%23.8%-2.4%
    P/E Multiple4.85.311.2%
    Shares Outstanding (Mil)42412.5%
    Cumulative Contribution7.1%

    LTM = Last Twelve Months as of date shown

    Market Drivers

    6/30/2026 to 10/12/2026
    ReturnCorrelation
    RNR7.1% 
    Market (SPY)4.2%-22.1%
    Sector (XLF)2.7%22.6%

    Fundamental Drivers

    The 14.3% change in RNR stock from 3/31/2026 to 10/12/2026 was primarily driven by a 13.4% change in the company's Net Income Margin (%).
    (LTM values as of)331202610122026Change
    Stock Price ($)296.46338.8714.3%
    Change Contribution By: 
    Total Revenues ($ Mil)12,77711,063-13.4%
    Net Income Margin (%)21.0%23.8%13.4%
    P/E Multiple4.95.39.6%
    Shares Outstanding (Mil)44416.2%
    Cumulative Contribution14.3%

    LTM = Last Twelve Months as of date shown

    Market Drivers

    3/31/2026 to 10/12/2026
    ReturnCorrelation
    RNR14.3% 
    Market (SPY)20.0%-30.8%
    Sector (XLF)11.9%22.2%

    Fundamental Drivers

    The 34.2% change in RNR stock from 9/30/2025 to 10/12/2026 was primarily driven by a 53.5% change in the company's Net Income Margin (%).
    (LTM values as of)930202510122026Change
    Stock Price ($)252.54338.8734.2%
    Change Contribution By: 
    Total Revenues ($ Mil)12,88611,063-14.1%
    Net Income Margin (%)15.5%23.8%53.5%
    P/E Multiple6.05.3-10.6%
    Shares Outstanding (Mil)474113.9%
    Cumulative Contribution34.2%

    LTM = Last Twelve Months as of date shown

    Market Drivers

    9/30/2025 to 10/12/2026
    ReturnCorrelation
    RNR34.2% 
    Market (SPY)17.8%-22.9%
    Sector (XLF)3.4%12.8%

    Fundamental Drivers

    The 74.4% change in RNR stock from 9/30/2023 to 10/12/2026 was primarily driven by a 323.3% change in the company's Net Income Margin (%).
    (LTM values as of)930202310122026Change
    Stock Price ($)194.25338.8774.4%
    Change Contribution By: 
    Total Revenues ($ Mil)7,34811,06350.6%
    Net Income Margin (%)5.6%23.8%323.3%
    P/E Multiple21.65.3-75.3%
    Shares Outstanding (Mil)464110.9%
    Cumulative Contribution74.4%

    LTM = Last Twelve Months as of date shown

    Market Drivers

    9/30/2023 to 10/12/2026
    ReturnCorrelation
    RNR74.4% 
    Market (SPY)88.3%12.3%
    Sector (XLF)73.2%30.1%

    Return vs. Risk

    Price Returns Compared

     202120222023202420252026Total [1]
    Returns
    RNR Return3%10%7%28%14%18%109%
    Peers Return16%27%10%32%9%7%147%
    S&P 500 Return27%-19%24%23%16%14%108%

    Monthly Win Rates [3]
    RNR Win Rate58%58%58%58%75%70% 
    Peers Win Rate55%55%57%58%55%54% 
    S&P 500 Win Rate75%42%67%75%67%50% 

    Max Drawdowns [4]
    RNR Max Drawdown-20%-27%-20%-16%-16%-12% 
    Peers Max Drawdown-18%-17%-19%-14%-18%-14% 
    S&P 500 Max Drawdown-5%-25%-10%-8%-19%-9% 

    [1] Cumulative total returns since the beginning of 2021
    [2] Peers: ACGL, EG, AXS, RGA, WRB. See RNR Returns vs. Peers.
    [3] Win Rate = % of calendar months in which monthly returns were positive
    [4] Max drawdown represents maximum peak-to-trough decline within a year
    [5] 2026 data is for the year up to 10/12/2026 (YTD)

    How Low Can It Go

    EventRNRS&P 500
    Summer-Fall 2023 Five Percent Yield Shock
      % Loss-12.2%-9.5%
      % Gain to Breakeven13.9%10.5%
      Time to Breakeven27 days24 days
    2023 SVB Regional Banking Crisis
      % Loss-16.7%-6.7%
      % Gain to Breakeven20.0%7.1%
      Time to Breakeven110 days31 days
    2022 Inflation Shock & Fed Tightening
      % Loss-25.4%-24.5%
      % Gain to Breakeven34.1%32.4%
      Time to Breakeven93 days427 days
    2020 COVID-19 Crash
      % Loss-39.6%-33.7%
      % Gain to Breakeven65.7%50.9%
      Time to Breakeven1028 days140 days
    Q4 2018 Fed Policy Error / Growth Scare
      % Loss-13.9%-19.2%
      % Gain to Breakeven16.2%23.8%
      Time to Breakeven26 days105 days
    2013 Taper Tantrum
      % Loss-10.5%-0.2%
      % Gain to Breakeven11.8%0.2%
      Time to Breakeven118 days1 days

    Compare to ACGL, EG, AXS, RGA, WRB

    In The Past

    RenaissanceRe's stock fell -4.1% during the 2025 US Tariff Shock. Such a loss loss requires a 4.3% gain to breakeven.

    Preserve Wealth

    Limiting losses and compounding gains is essential to preserving wealth.

    Asset Allocation

    Actively managed asset allocation strategies protect wealth. Learn more.

    EventRNRS&P 500
    2022 Inflation Shock & Fed Tightening
      % Loss-25.4%-24.5%
      % Gain to Breakeven34.1%32.4%
      Time to Breakeven93 days427 days
    2020 COVID-19 Crash
      % Loss-39.6%-33.7%
      % Gain to Breakeven65.7%50.9%
      Time to Breakeven1028 days140 days
    2008-2009 Global Financial Crisis
      % Loss-40.7%-53.4%
      % Gain to Breakeven68.7%114.4%
      Time to Breakeven614 days1085 days

    Compare to ACGL, EG, AXS, RGA, WRB

    In The Past

    RenaissanceRe's stock fell -4.1% during the 2025 US Tariff Shock. Such a loss loss requires a 4.3% gain to breakeven.

    Preserve Wealth

    Limiting losses and compounding gains is essential to preserving wealth.

    Asset Allocation

    Actively managed asset allocation strategies protect wealth. Learn more.

    About RenaissanceRe (RNR)

    RenaissanceRe Holdings Ltd. (RNR) is a Bermuda-based company that specializes in providing reinsurance and insurance products globally. Essentially, RenaissanceRe acts as an insurer for other insurance and reinsurance companies, helping them manage and transfer significant risks. The company operates through two primary segments: Property, and Casualty and Specialty, enabling it to cover a broad spectrum of complex and large-scale exposures for its clients.

    The Property segment is primarily focused on insuring against catastrophic events. It offers property catastrophe excess of loss reinsurance and retrocessional reinsurance, protecting clients from immense financial losses due to natural disasters like hurricanes, earthquakes, typhoons, and floods, as well as man-made catastrophes such as terrorism. This segment also provides other property-related coverages, including proportional reinsurance and multi-line reinsurance, serving insurance and reinsurance companies globally.

    RenaissanceRe's Casualty and Specialty segment offers a highly diverse array of insurance and reinsurance products beyond catastrophic property risks. This includes coverage for areas such as directors and officers liability, medical malpractice, professional indemnity, general liability, and workers' compensation. Furthermore, it provides specialized coverages for financial and mortgage guaranty, political risk, cyber risks, marine, aviation, and satellite operations. The company distributes its extensive range of products and services to various clients in the United States and internationally, primarily through intermediaries.

    AI Analysis | Feedback

    Here are 1-3 brief analogies to describe RenaissanceRe (RNR):

    • The Intel Inside of the insurance world.
    • The Goldman Sachs of risk management for insurance companies.

    AI Analysis | Feedback

    • Property Catastrophe Reinsurance: Insures insurance and reinsurance companies against large-scale natural and man-made catastrophes.
    • Other Property Reinsurance: Provides various property-related reinsurance products, including proportional, per risk, and multi-line offerings.
    • Casualty Reinsurance: Covers a broad range of general liability risks, such as automobile, employer's liability, workers' compensation, and general liability.
    • Professional Indemnity Reinsurance: Offers coverage for professional liabilities, including directors and officers, medical malpractice, and general professional indemnity.
    • Specialty Reinsurance: Encompasses diverse lines like financial guaranty, political risk, surety, trade credit, accident and health, aviation, cyber, energy, marine, and terrorism.

    AI Analysis | Feedback

    RenaissanceRe (RNR) sells primarily to other companies. Based on the provided description, its major customers are:

    • Insurance companies
    • Reinsurance companies

    The company provides reinsurance and retrocessional reinsurance products, meaning it serves other entities in the insurance industry by helping them manage their risk exposure to various catastrophic and specialty events.

    AI Analysis | Feedback

    null

    AI Analysis | Feedback

    Kevin J. O'Donnell, President and Chief Executive Officer

    Kevin J. O'Donnell joined RenaissanceRe in 1996 and has served as President since November 2012 and Chief Executive Officer since July 2013. His previous roles at the company include Executive Vice President and Global Chief Underwriter, President of Renaissance Reinsurance Ltd., and Chief Underwriting Officer for the company's joint ventures, Top Layer Re and DaVinci Re.

    Robert Qutub, Executive Vice President and Chief Financial Officer

    Robert Qutub joined RenaissanceRe as Executive Vice President and Chief Financial Officer in August 2016. Prior to joining RenaissanceRe, Mr. Qutub served as Chief Financial Officer and Treasurer for MSCI Inc. from July 2012 to May 2016. Before his time at MSCI, he spent 18 years at Bank of America, where he held various segment Chief Financial Officer roles, including for Global Consumer and Business Banking, Global Banking and Markets, and Global Wealth Management.

    Shannon Lowry Bender, Executive Vice President, Group General Counsel and Corporate Secretary

    Shannon Lowry Bender became Executive Vice President, Group General Counsel and Corporate Secretary at RenaissanceRe in 2021. She is responsible for legal, regulatory, government affairs, and compliance matters globally. Before joining RenaissanceRe, Ms. Bender was Senior Vice President and Chief Corporate Counsel of CIT Group Inc., and prior to that, a Partner at Fried, Frank, Harris, Shriver & Jacobson LLP in New York.

    Ross Curtis, Executive Vice President and Chief Portfolio Officer

    Ross Curtis is the Executive Vice President and Chief Portfolio Officer for RenaissanceRe, a role he assumed in January 2023. He oversees the execution of the company's gross-to-net strategy, risk tolerance, portfolio optimization, and deployed underwriting capital. Mr. Curtis joined RenaissanceRe in 1999 as a Catastrophe Reinsurance Analyst. He previously served as Group Chief Underwriting Officer for RenaissanceRe from 2014 to 2022 and as Active Underwriter of Syndicate 1458 in London from 2010 to 2014. He was appointed to the Executive Committee in May 2010.

    David Marra, Executive Vice President and Group Chief Underwriting Officer

    David Marra is the Executive Vice President and Group Chief Underwriting Officer for RenaissanceRe, a position he has held since January 2023. In this role, he directs the company's underwriting strategy, including risk appetite and client engagement. Mr. Marra joined RenaissanceRe in 2008. His prior roles include President of Renaissance Reinsurance U.S. Inc. from March 2016 to January 2023 and Chief Underwriting Officer for Casualty & Specialty at RenaissanceRe Holdings Ltd. from June 2014 to January 2023.

    AI Analysis | Feedback

    For RenaissanceRe (symbol: RNR), key risks to the business include:
    1. Exposure to Catastrophic Events: RenaissanceRe's core business involves providing property catastrophe excess of loss reinsurance and retrocessional reinsurance, meaning it assumes significant risk from natural and man-made disasters such as hurricanes, earthquakes, typhoons, tsunamis, winter storms, floods, fires, windstorms, and acts of terrorism. Consequently, the frequency and severity of these events directly impact the company's financial performance. For example, in 2025, the company's combined ratio was impacted by 15.3 percentage points from large loss events and 4.0 percentage points from Hurricane Melissa in the fourth quarter alone. The company’s business risk profile is under pressure from sector headwinds, particularly in property-catastrophe lines, and it maintains a high-risk position due to substantial exposure to such severity risks.
    2. Underwriting and Pricing Risk: The ability to accurately assess and price risks is fundamental to a reinsurance company's profitability. RenaissanceRe has experienced a deterioration in its combined ratio, which increased from 77.9% in 2023 to 83.9% in 2024 and further to 87.2% in 2025, indicating a shrinking share of premiums retained after covering claims. This trend highlights the challenges in maintaining disciplined underwriting and effective risk selection, especially if softer property and casualty pricing affects margins.
    3. Increased Debt Levels and Interest Expense: As of December 31, 2025, RenaissanceRe carried $2.3 billion in debt, resulting in a total debt-to-capital ratio of 16.7%, which is above the industry average of 15.4%. This elevated debt has led to a significant increase in interest expenses, which rose by 28.1% year-over-year in 2024 and 35% in the fourth quarter of 2025, potentially weighing on the company's margins.

    AI Analysis | Feedback

    null

    AI Analysis | Feedback

    RenaissanceRe Holdings Ltd. (RNR) operates in the global reinsurance and insurance markets, primarily through its Property, and Casualty and Specialty segments. The addressable markets for its main products and services are substantial on a global scale.

    Global Reinsurance Market

    The global reinsurance market was valued at approximately USD 621.39 billion in 2025. It is projected to grow to about USD 1403.7 billion by 2034, demonstrating a compound annual growth rate (CAGR) of 9.6% during this period. In 2025, Europe held the largest share of the global reinsurance market, accounting for 37%, with a valuation of USD 230.22 billion. The U.S. market is projected to reach USD 194.07 billion by 2026.

    Property Reinsurance Segment

    This segment includes property catastrophe excess of loss reinsurance and other property classes. The global property and casualty (P&C) reinsurance market, which encompasses these offerings, was valued at approximately USD 509.34 billion in 2025. This market grew to an estimated USD 566.47 billion in 2026, and is projected to reach USD 889.04 billion by 2030, with a CAGR of 11.9%. In 2025, property and casualty reinsurance collectively held 62.40% of the overall reinsurance market.

    Casualty and Specialty Reinsurance Segment

    The Casualty and Specialty segment covers a diverse range of products including directors and officers, medical malpractice, professional indemnity, workers' compensation, general liability, financial and mortgage guaranty, political risk, surety, trade credit, cyber, marine, and energy reinsurance. The broader non-life reinsurance segment, which includes property, casualty, and other general insurance lines, is significant, accounting for 67.05% of the global reinsurance market in 2026.

    For specialty lines within reinsurance (such as cyber, aviation, marine, and energy), these are projected to grow at an 11.18% CAGR, contributing over USD 20 billion in ceded premium by 2031.

    As an indicator of the underlying demand for specialty reinsurance, the global specialty insurance market was valued at USD 104.7 billion in 2021 and is projected to grow to USD 279 billion by 2031, exhibiting a CAGR of 10.6%. Europe held a significant 35% share of the specialty insurance industry in 2021.

    AI Analysis | Feedback

    RenaissanceRe Holdings Ltd. (RNR) is expected to drive future revenue growth over the next 2-3 years through a diversified strategy focusing on three core areas. These drivers are consistently highlighted in company communications and analyst commentary. Here are the expected drivers of future revenue growth for RenaissanceRe: * Growth in Underwriting Business: RenaissanceRe aims to expand its revenue through its core underwriting operations across property, casualty, and specialty reinsurance lines. The company anticipates opportunities in catastrophe premiums and maintains a disciplined approach to underwriting. * Expansion of Capital Partners Segment and Fee Income: A significant driver of future revenue growth is the expansion of RenaissanceRe's Capital Partners business, which generates relatively low volatility fee income. This segment contributes to the company's diversified income streams. * Increased Net Investment Income: The company expects substantial net investment income from its prudent investment portfolio to be a key contributor to revenue growth.

    AI Analysis | Feedback

    Capital Allocation Decisions of RenaissanceRe (RNR)

    Share Repurchases

    • In 2025, RenaissanceRe repurchased approximately $1.6 billion of common shares, resulting in a 12.8% reduction in its share count.
    • The company repurchased $650.5 million of common shares in the fourth quarter of 2025 alone.
    • Since the first quarter of 2024, RenaissanceRe has returned over $1.7 billion of capital to shareholders through share buybacks.
    • As of February 2026, the company's Board of Directors renewed its share repurchase program, increasing the total current authorization to $750.0 million.

    Share Issuance

    • RenaissanceRe's shares outstanding increased by approximately 7.84% in 2024, reaching 0.051 billion shares from 0.048 billion in 2023.
    • In 2023, shares outstanding grew by about 10.61% to 0.048 billion, up from 0.043 billion in 2022.

    Inbound Investments

    • In 2024, RenaissanceRe raised $857.4 million of third-party capital in its Capital Partners unit, with an additional $237.8 million secured from third-party investors effective January 1, 2025.
    • The company leverages third-party capital through managed joint ventures such as Medici and Vermeer, where external partners like Stichting Pensioenfonds Zorg en Welzijn (represented by PGGM) participate in economic benefits.

    Outbound Investments

    • Effective April 1, 2022, RenaissanceRe launched Fontana, a strategic joint venture focused on underwriting Casualty and Specialty risks.
    • The company periodically invests in new or existing managed joint ventures and funds, and contributes cash to investment subsidiaries to support growth initiatives.

    Capital Expenditures

    • While specific dollar values for traditional capital expenditures are not extensively detailed, RenaissanceRe emphasizes ongoing investments in business infrastructure.
    • Strategic initiatives, particularly in 2025, included investments in underwriting system upgrades and the integration of artificial intelligence for operational efficiency.

    Peer Outperformance in Reinsurance

    RNR has outperformed 60% of its 5 Reinsurance peers over 5Y. Reinsurance ranks 1st of 18 industries in Financials by median 5Y return. That makes it one of the strongest corners of the sector.
    Share of Reinsurance constituents that RNR has outperformed, by holding period. Peers without a full price history over a given window are excluded from that window.
    1Y
    60%
    of 5 industry peers · 30.8% return
    3Y
    40%
    of 5 industry peers · 60.6% return
    5Y
    60%
    of 5 industry peers · 140.6% return
    No Reinsurance peer with a comparable growth profile has beaten RNR by more than 20pp over 5Y.
    Median price return by industry across the Financials sector, ranked by 5Y. Reinsurance is RNR's own industry. Use this to see which corners of the sector have carried the returns.
    Industry Names 1Y med3Y med5Y med Top null by 5Y
    Reinsurance ← 6 20.5%64.5%116.1% SPNT 175% · RGA 141% · RNR 141%
    Diversified Banks 12 33.2%128.1%98.2% CM 138% · JPM 129% · RY 124%
    Investment Banking & Brokerage 13 -2.6%101.6%94.7% IBKR 403% · SNEX 199% · HOOD 169%
    Life & Health Insurance 20 12.6%51.7%83.3% JXN 489% · UNM 291% · MFC 175%
    Property & Casualty Insurance 42 8.3%72.0%61.3% PGR 172% · TRV 161% · ACGL 150%
    Multi-Sector Holdings 3 3.9%50.0%57.6% BRK-B 86% · VOYA 58% · JEF 36%
    Multi-line Insurance 9 7.1%64.0%54.9% GNW 112% · L 93% · AIZ 81%
    Regional Banks 263 30.3%92.2%49.1% CBC 220% · FCNCA 152% · FBP 135%
    Financial Exchanges & Data 15 3.8%43.0%31.8% VIRT 163% · CBOE 154% · CME 69%
    Consumer Finance 30 10.0%87.1%22.7% ENVA 389% · EZPW 289% · FCFS 166%
    Asset Management & Custody Banks 81 -7.6%17.9%15.4% WT 341% · SII 263% · VCTR 260%
    Diversified Financial Services 4 -2.6%17.7%13.7% FRHC 168% · EQH 91%
    Insurance Brokers 15 -21.6%-2.6%9.6% LIFE 295% · ARX 88% · AJG 57%
    Commercial & Residential Mortgage Finance 14 -53.6%24.4%-3.9% FNMA 389% · FMCC 344% · ACT 175%
    Specialized Finance 3 14.5%35.6%-12.9% CACC -13% · HASI -16%
    Mortgage REITs 33 -15.1%-3.4%-32.7% RITM 26% · DX 19% · AGNC 8%
    Transaction & Payment Processing Services 17 0.3%-3.4%-38.5% V 80% · MA 78% · CPAY 56%
    Diversified Capital Markets 20 -44.6%16.6%-61.3% LPLA 102% · TW 35% · RIOT -35%
    Median of constituents with a full price history over each window. Top names are limited to companies above $2B market cap.

    Latest Trefis Analyses

    Recent Active Movers

    Top Gainers

    TickerCompanyMkt Cap (B)1W RtnYTD Rtn
    PCRXPacira BioSciences1.445.1%40.5%
    OPCHOption Care Health4.833.1%-2.4%
    PENGPenguin Solutions4.030.4%304.7%
    FIGSFIGS3.030.2%56.2%
    HPKHighPeak Energy1.220.0%104.9%
    CCICrown Castle35.119.9%-5.3%
    WINGWingstop3.418.0%-46.8%
    SEZLSezzle4.417.7%105.6%
    HAEHaemonetics5.516.6%52.3%
    SNAPSnap10.916.4%-19.1%

    Top Losers

    TickerCompanyMkt Cap (B)1W RtnYTD Rtn
    AVBPArriVent BioPharma0.8-42.2%-18.2%
    ALMRAlamar Biosciences1.4-36.4%10.2%
    CTNMContineum Therapeutics0.3-32.7%-25.1%
    AXTIAXT3.8-28.5%279.1%
    EMATEvolution Metals & Technologies0.9-28.5%-93.1%
    NUAINew Era Energy & Digital0.4-28.3%48.1%
    EOSEEos Energy Enterprises0.8-26.9%-79.1%
    PACBPacific Biosciences of California0.7-26.8%12.3%
    ANGOAngioDynamics0.5-26.6%-11.2%
    TWSTTwist Bioscience9.5-25.9%378.8%

    Top Gainers

    TickerCompanyMkt Cap (B)1M RtnYTD Rtn
    MYPSPLAYSTUDIOS0.5761.5%548.8%
    KODKodiak Sciences6.2201.8%255.0%
    GRALGRAIL5.980.2%60.5%
    DNAGinkgo Bioworks0.774.7%41.9%
    IOVAIovance Biotherapeutics6.669.3%433.3%
    PACBPacific Biosciences of California0.761.5%12.3%
    PEverpure51.758.2%131.9%
    PENGPenguin Solutions4.054.7%304.7%
    BALYBallys0.852.6%-15.3%
    PTCPTC22.348.6%11.6%

    Top Losers

    TickerCompanyMkt Cap (B)1M RtnYTD Rtn
    CTVACorteva8.9-84.1%-80.0%
    XNDUXanadu Quantum Technologies1.0-59.5%-69.7%
    LQDALiquidia2.5-58.5%-19.8%
    EMATEvolution Metals & Technologies0.9-52.3%-93.1%
    QUREuniQure1.4-50.9%-8.7%
    GLASGlass House Brands0.4-48.5%-53.9%
    AVBPArriVent BioPharma0.8-43.2%-18.2%
    NKTRNektar Therapeutics1.3-42.9%-5.8%
    CTNMContineum Therapeutics0.3-42.2%-25.1%
    FRMIFermi2.1-40.9%-59.4%

    More From Trefis

    Research & Analysis

    Invest in Strategies

    Wealth Management

    Peer Comparisons

    Peers to compare with:

    Financials

    RNRACGLEGAXSRGAWRBMedian
    NameRenaissa.Arch Cap.Everest Axis Cap.Reinsura.WR Berkl. 
    Mkt Price338.9497.18373.7197.26260.1372.91178.69
    Mkt Cap14.033.414.57.216.928.415.7
    Rev LTM11,06318,59516,4356,85125,87814,91815,676
    Op Inc LTM-------
    FCF LTM3,6066,0552,0002,4555,1993,4703,538
    FCF 3Y Avg3,5616,2823,7861,1916,3453,4003,674
    CFO LTM3,6066,1002,0002,4555,1993,6033,604
    CFO 3Y Avg3,5616,3303,7861,1916,3483,5013,674

    Growth & Margins

    RNRACGLEGAXSRGAWRBMedian
    NameRenaissa.Arch Cap.Everest Axis Cap.Reinsura.WR Berkl. 
    Rev Chg LTM-14.1%0.2%-6.2%12.1%19.5%4.8%2.5%
    Rev Chg 3Y Avg17.1%17.5%7.9%8.1%16.3%8.7%12.5%
    Rev Chg Q-13.7%-9.7%-11.2%13.8%18.2%2.7%-3.5%
    QoQ Delta Rev Chg LTM-3.8%-2.5%-2.9%3.2%4.1%0.7%-0.9%
    Op Inc Chg LTM-------
    Op Inc Chg 3Y Avg-------
    Op Mgn LTM-------
    Op Mgn 3Y Avg-------
    QoQ Delta Op Mgn LTM-------
    CFO/Rev LTM32.6%32.8%12.2%35.8%20.1%24.2%28.4%
    CFO/Rev 3Y Avg31.1%36.9%22.9%18.5%28.3%25.1%26.7%
    FCF/Rev LTM32.6%32.6%12.2%35.8%20.1%23.3%27.9%
    FCF/Rev 3Y Avg31.1%36.7%22.9%18.5%28.2%24.4%26.3%

    Valuation

    RNRACGLEGAXSRGAWRBMedian
    NameRenaissa.Arch Cap.Everest Axis Cap.Reinsura.WR Berkl. 
    Mkt Cap14.033.414.57.216.928.415.7
    P/S1.31.80.91.00.71.91.2
    P/Op Inc-------
    P/EBIT3.16.36.15.17.411.26.2
    P/E5.37.17.66.511.214.77.3
    P/CFO3.95.57.22.93.37.94.7
    Total Yield19.3%14.1%15.5%17.3%10.4%8.5%14.8%
    Dividend Yield0.5%0.0%2.2%1.9%1.4%1.7%1.6%
    FCF Yield 3Y Avg29.7%17.7%24.6%17.6%47.0%13.4%21.2%
    D/E0.20.10.20.20.30.10.2
    Net D/E-0.8-0.3-1.0-0.6-0.8-0.9-0.8

    Returns

    RNRACGLEGAXSRGAWRBMedian
    NameRenaissa.Arch Cap.Everest Axis Cap.Reinsura.WR Berkl. 
    1M Rtn4.4%1.1%0.5%-0.5%4.6%4.5%2.8%
    3M Rtn5.8%-5.7%-0.6%-14.7%9.7%-1.1%-0.8%
    6M Rtn10.4%0.1%13.4%-1.9%27.1%10.0%10.2%
    12M Rtn30.9%5.1%10.4%2.8%37.9%-3.5%7.8%
    3Y Rtn60.7%21.4%0.2%79.1%87.6%85.1%69.9%
    1M Excs Rtn2.5%-0.8%-1.4%-2.5%2.6%2.5%0.8%
    3M Excs Rtn2.6%-7.8%-2.5%-16.6%8.1%-2.1%-2.3%
    6M Excs Rtn-3.0%-13.3%-0.1%-15.3%13.7%-3.4%-3.2%
    12M Excs Rtn15.4%-10.6%-7.2%-13.7%20.0%-19.2%-8.9%
    3Y Excs Rtn-15.7%-58.2%-80.5%-0.5%10.0%0.6%-8.1%

    Comparison Analyses

    null

    Clinical Pipeline

    Drug CandidateIndicationPhase 3 TrialsEst. Primary Completion
    hu1418K322A (hu14)High-Risk Neuroblastoma1Mar 2031
    Active Phase 3 studies led by the company. Source: ClinicalTrials.gov · Updated 8/28/2026

    Financials

    $ Mil | FY: 12/312026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q3
    Period End6/30/20263/31/202612/31/20259/30/20256/30/20253/31/202512/31/20249/30/20246/30/20243/31/202412/31/20239/30/2023
    Filing Date7/23/20264/29/20262/11/202610/29/20257/24/20254/24/20252/12/202511/7/20247/25/20245/1/20242/21/202411/2/2023
    Key Financials Quarterly            
    Total Revenue2,7512,1742,9523,1863,1863,4532,2793,9682,8162,5853,2251,825
    Net Income663293760917835170-1901,1825043741,586203
    EPS15.546.6016.8219.4717.253.29-3.9522.689.446.9630.513.81
    Key Financials TTM            
    Total Revenue TTM11,06311,49912,77712,10312,88612,51511,64812,59410,4519,4819,0917,888
    Net Income TTM2,6332,8062,6821,7321,9981,6671,8703,6462,6662,3622,5611,433
    Growth Rates Quarterly            
    Total Revenue Growth-13.7%-37.0%29.6%-19.7%13.2%33.5%-29.3%117.4%52.6%17.8%59.5%42.1%
    Net Income Growth-20.6%72.6%501.0%-22.5%65.8%-54.5%-112.0%483.0%152.1%-34.8%247.0%124.8%
    Margins Quarterly            
    Net Income Margin24.1%13.5%25.8%28.8%26.2%4.9%-8.3%29.8%17.9%14.5%49.2%11.1%
    Cash & Debt            
    Total Cash13,27613,53814,6907,7207,0926,68711,0385,8765,9886,2466,4827,715
    Total Debt2,3312,3302,3292,2292,2632,7541,8871,9361,9601,8841,9591,883
    Net Debt / (Cash)-10,945-11,208-12,361-5,491-4,829-3,933-9,151-3,940-4,028-4,361-4,523-5,832
    Cash Flows Quarterly            
    FCF from Operations8526884831,5831,4701587791,4901,212683512772
    Cash Flows TTM            
    FCF from Operations TTM3,6064,2233,6933,9893,8963,6394,1653,8983,1812,1591,9122,132
    Returns to Shareholders Quarterly            
    Dividends171818191920202020212019
    Share Repurchases350352660208374358452107109-0-0-0
    Return on Invested Capital (ROIC) Quarterly            
    ROIC------------
    Return on Invested Capital (ROIC) TTM            
    ROIC TTM------------

    Segment Financials

    Net Income by Segment
    $ Mil20152014201220112010
    Other153124167118204
    Total153124167118204


    Price Behavior

    Price Behavior
    Market Price$338.87 
    Market Cap ($ Bil)14.0 
    First Trading Date07/27/1995 
    Distance from 52W High0.0% 
       50 Days200 Days
    DMA Price$325.45$304.76
    DMA Trendupup
    Distance from DMA4.1%11.2%
     3M1YR
    Volatility22.1%24.1%
    Downside Capture-44.76-75.98
    Upside Capture-5.07-30.92
    Correlation (S&P 500)-16.8%-22.5%
    RNR Betas & Captures as of 9/30/2026

     1M2M3M6M1Y3Y
    Beta0.150.03-0.47-0.58-0.420.21
    Up Beta0.590.21-0.950.10-0.110.30
    Down Beta-1.15-1.12-0.52-1.66-0.710.30
    Up Capture6%9%-25%-25%-14%5%
    Bmk +ve Days6162766132424
    Stock +ve Days8202962130398
    Down Capture64%16%-39%-100%-112%3%
    Bmk -ve Days16263760120328
    Stock -ve Days14223564122354

    [1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
    Based On 1-Year Data
    Annualized
    Return    		Annualized
    Volatility    		Sharpe
    Ratio    		Correlation
    with RNR
    RNR31.5%24.1%1.07-
    Sector ETF (XLF)4.5%14.8%0.0812.6%
    Equity (SPY)17.0%13.0%0.93-23.3%
    Gold (GLD)4.6%29.5%0.15-10.1%
    Commodities (DBC)48.0%20.9%1.77-3.7%
    Real Estate (VNQ)6.2%13.8%0.1922.7%
    Bitcoin (BTCUSD)-32.3%44.3%-0.76-16.1%

    Smart multi-asset allocation framework can stack odds in your favor. Learn How
    Based On 5-Year Data
    Annualized
    Return    		Annualized
    Volatility    		Sharpe
    Ratio    		Correlation
    with RNR
    RNR20.4%27.8%0.67-
    Sector ETF (XLF)9.6%18.3%0.3836.5%
    Equity (SPY)14.1%17.1%0.6322.5%
    Gold (GLD)18.3%18.9%0.78-3.7%
    Commodities (DBC)9.9%19.5%0.390.5%
    Real Estate (VNQ)1.5%18.8%-0.0324.4%
    Bitcoin (BTCUSD)11.0%52.0%0.396.6%

    Smart multi-asset allocation framework can stack odds in your favor. Learn How
    Based On 10-Year Data
    Annualized
    Return    		Annualized
    Volatility    		Sharpe
    Ratio    		Correlation
    with RNR
    RNR11.8%27.1%0.44-
    Sector ETF (XLF)13.1%22.1%0.5447.8%
    Equity (SPY)15.4%17.9%0.7338.6%
    Gold (GLD)11.8%16.4%0.580.3%
    Commodities (DBC)8.3%18.1%0.3711.0%
    Real Estate (VNQ)4.6%20.7%0.1840.2%
    Bitcoin (BTCUSD)63.4%66.2%1.037.2%

    Smart multi-asset allocation framework can stack odds in your favor. Learn How

    Short Interest

    Short Interest: As Of Date9302026
    Short Interest: Shares Quantity1.3 Mil
    Short Interest: % Change Since 9152026-15.4%
    Average Daily Volume0.3 Mil
    Days-to-Cover Short Interest3.8 days
    Basic Shares Quantity41.4 Mil
    Short % of Basic Shares3.1%

    Returns Analyses

    Earnings Returns History

    Updated 8/24/2026
    Expand for More
     Forward Returns
    Earnings Date1D Returns5D Returns21D Returns
    7/22/2026-0.7%4.0%0.8%
    4/28/2026-2.2%-2.8%-8.0%
    2/3/20265.0%3.3%4.1%
    10/28/20256.9%13.4%12.7%
    7/23/20250.7%3.0%5.0%
    4/23/2025-5.0%0.8%-0.5%
    1/28/2025-8.6%-10.3%-9.8%
    11/6/2024-4.4%-6.3%0.6%
    ...
    SUMMARY STATS   
    # Positive71214
    # Negative171210
    Median Positive5.0%3.3%5.8%
    Median Negative-2.5%-4.4%-8.5%
    Max Positive7.1%17.5%18.5%
    Max Negative-8.6%-10.3%-14.4%
     Collapse to Preview
     Forward Returns
    Earnings Date1D Returns5D Returns21D Returns
    7/22/2026-0.7%4.0%0.8%
    4/28/2026-2.2%-2.8%-8.0%
    2/3/20265.0%3.3%4.1%
    10/28/20256.9%13.4%12.7%
    7/23/20250.7%3.0%5.0%
    4/23/2025-5.0%0.8%-0.5%
    1/28/2025-8.6%-10.3%-9.8%
    11/6/2024-4.4%-6.3%0.6%
    7/24/2024-2.3%3.2%10.0%
    4/30/2024-0.4%2.7%3.8%
    1/30/20246.4%5.9%4.5%
    11/1/2023-8.1%-9.3%-6.0%
    7/25/2023-0.5%-6.9%-9.8%
    5/2/2023-2.5%-4.4%-14.4%
    1/31/20237.1%10.0%9.4%
    11/1/20224.5%17.5%18.5%
    7/25/2022-3.6%-9.8%-3.2%
    5/3/2022-0.8%-1.1%3.8%
    1/25/2022-3.4%-4.4%-9.0%
    10/25/20212.8%-1.3%11.8%
    7/22/2021-1.4%1.1%7.4%
    4/28/2021-2.5%-2.5%-9.5%
    1/26/2021-2.2%0.7%6.6%
    10/27/2020-4.7%-3.9%-0.4%
    SUMMARY STATS   
    # Positive71214
    # Negative171210
    Median Positive5.0%3.3%5.8%
    Median Negative-2.5%-4.4%-8.5%
    Max Positive7.1%17.5%18.5%
    Max Negative-8.6%-10.3%-14.4%

    SEC Filings

    Expand for More
    Report DateFiling DateFiling
    06/30/202607/23/202610-Q
    03/31/202604/29/202610-Q
    12/31/202502/11/202610-K
    09/30/202510/29/202510-Q
    06/30/202507/24/202510-Q
    03/31/202504/24/202510-Q
    12/31/202402/12/202510-K
    09/30/202411/07/202410-Q
    06/30/202407/25/202410-Q
    03/31/202405/01/202410-Q
    12/31/202302/21/202410-K
    09/30/202311/02/202310-Q
    06/30/202307/26/202310-Q
    03/31/202305/03/202310-Q
    12/31/202202/08/202310-K
    09/30/202211/02/202210-Q
     Collapse to Preview
    Report DateFiling DateFiling
    06/30/202607/23/202610-Q
    03/31/202604/29/202610-Q
    12/31/202502/11/202610-K
    09/30/202510/29/202510-Q
    06/30/202507/24/202510-Q
    03/31/202504/24/202510-Q
    12/31/202402/12/202510-K
    09/30/202411/07/202410-Q
    06/30/202407/25/202410-Q
    03/31/202405/01/202410-Q
    12/31/202302/21/202410-K
    09/30/202311/02/202310-Q
    06/30/202307/26/202310-Q
    03/31/202305/03/202310-Q
    12/31/202202/08/202310-K
    09/30/202211/02/202210-Q
    06/30/202207/26/202210-Q
    03/31/202205/04/202210-Q
    12/31/202102/04/202210-K
    09/30/202110/26/202110-Q
    06/30/202107/23/202110-Q
    03/31/202104/29/202110-Q
    12/31/202002/05/202110-K
    09/30/202010/28/202010-Q
    06/30/202007/29/202010-Q
    03/31/202005/07/202010-Q
    12/31/201902/07/202010-K
    09/30/201910/30/201910-Q

    Insider Activity

    Updated 9/3/2026
    Expand for More
    #OwnerTitleHoldingActionFiling DatePriceSharesTransacted
    Value    		Value of
    Held Shares    		Form
    1Curtis, RossEVP,Chief Portfolio OfficerDirectSell9032026337.609,6233,248,70552,662,241Form
    2Curtis, RossEVP,Chief Portfolio OfficerDirectSell8272026335.00377126,29555,480,690Form
    3Curtis, RossEVP,Chief Portfolio OfficerDirectSell8252026330.005,0001,650,00054,777,030Form
    4Curtis, RossEVP,Chief Portfolio OfficerDirectSell8172026325.005,0001,625,00055,572,075Form
    5Qutub, RobertEVP, Chief Financial OfficerDirectSell7282026333.035,0001,665,13424,279,987Form
     Collapse to Preview
    #OwnerTitleHoldingActionFiling DatePriceSharesTransacted
    Value    		Value of
    Held Shares    		Form
    1Curtis, RossEVP,Chief Portfolio OfficerDirectSell9032026337.609,6233,248,70552,662,241Form
    2Curtis, RossEVP,Chief Portfolio OfficerDirectSell8272026335.00377126,29555,480,690Form
    3Curtis, RossEVP,Chief Portfolio OfficerDirectSell8252026330.005,0001,650,00054,777,030Form
    4Curtis, RossEVP,Chief Portfolio OfficerDirectSell8172026325.005,0001,625,00055,572,075Form
    5Qutub, RobertEVP, Chief Financial OfficerDirectSell7282026333.035,0001,665,13424,279,987Form
    6Sanders, Carol P DirectSell5192026297.361,479439,7881,713,360Form
    7Qutub, RobertEVP, Chief Financial OfficerDirectSell2062026305.755,0001,528,75722,326,880Form
    8Curtis, RossEVP,Chief Portfolio OfficerDirectSell2062026305.005,0001,525,00050,877,965Form
    9Curtis, RossEVP,Chief Portfolio OfficerDirectSell2062026295.0015,0004,425,00050,684,835Form

    Investor Activity (13F)

    Updated Oct 13, 2026
    13F holdings as of Mar 31, 2026 (Q1 2026)

    Active managers (13F portfolio over $250M, at least 3 holdings) with a position over $5M that is either over 10% of their portfolio or held in a concentrated book of 50 or fewer total positions. Index/ETF, sovereign, bank, community-bank and charitable/donor-advised filers are excluded.

    Active ManagerValue% of PortfolioTotal PositionsQoQFiling
    SRB Corp$115.5 Mil7.1%44TRIM -7.5%13F
    Nepsis Inc.$17.0 Mil5.7%29Hold13F
    Lightrock Netherlands B.V.$16.3 Mil3.5%39ADD +15.8%13F
    Egerton Capital (UK) LLP$94.3 Mil1.0%24TRIM -35.3%13F
    Active ManagerValue% of PortfolioTotal PositionsQoQFiling
    Lightrock Netherlands B.V.$16.3 Mil3.5%39ADD +15.8%13F
    Active ManagerValue% of PortfolioTotal PositionsQoQFiling
    Egerton Capital (UK) LLP$94.3 Mil1.0%24TRIM -35.3%13F
    SRB Corp$115.5 Mil7.1%44TRIM -7.5%13F
    Active ManagerValue% of PortfolioTotal PositionsQoQFiling
    SRB Corp$115.5 Mil7.1%44TRIM -7.5%13F
    Egerton Capital (UK) LLP$94.3 Mil1.0%24TRIM -35.3%13F
    Nepsis Inc.$17.0 Mil5.7%29Hold13F
    Lightrock Netherlands B.V.$16.3 Mil3.5%39ADD +15.8%13F

    Industry Resources

    External Quote Links


    Prefer one of these to Trefis? Tell us why.
    Core Cache Last Updated: 10/12/2026